Abnormal Clones of T Cells Producing Interleukin-5 in Idiopathic Eosinophilia
- 7 October 1999
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 341 (15), 1112-1120
- https://doi.org/10.1056/nejm199910073411503
Abstract
The cause of persistent eosinophilia and the hypereosinophilic syndrome is unknown. Recent work suggests that in some patients with the hypereosinophilic syndrome, a clone of abnormal T cells produces large amounts of interleukin-5, a cytokine required for the growth and differentiation of eosinophils. We examined T-cell surface markers, rearranged T-cell–receptor genes, and in vitro production of cytokines by T cells from patients with idiopathic eosinophilia. The expression of surface molecules on T cells was measured by flow cytometry. Cytokine expression was measured by enzyme-linked immunosorbent assay, flow cytometry, and immunohistochemical analysis. To identify dominant (clonal) rearrangements of the T-cell receptor within the lymphocyte population, Southern blot analysis (β chain) and the polymerase chain reaction (γ chain) were performed according to standard protocols. Among 60 patients with idiopathic eosinophilia, 16 had circulating T cells with an aberrant immunophenotype. In each of these patients, the abnormal immunophenotype was unique. Evidence of clonal rearrangements of the T-cell receptor was obtained in 8 of the 16 patients. In most instances, the abnormal T cells expressed large amounts of surface proteins associated with T-cell activation (the α chain of the interleukin-2 receptor and the HLA-DR antigen). Moreover, the aberrant T cells produced large amounts of interleukin-5 in vitro. Clonal populations of abnormal T cells producing interleukin-5 occur in some patients with idiopathic eosinophilia.Keywords
This publication has 23 references indexed in Scilit:
- Comparative analysis of histologicai and immunohistological features in mycosis fungoides and Sézary syndromeJournal of Cutaneous Pathology, 1998
- Role of interleukin 10 in specific immunotherapy.Journal of Clinical Investigation, 1998
- Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide.Journal of Clinical Investigation, 1997
- Modulation of Apo-1/Fas (CD95)-induced programmed cell death in myeloma cells by interferon-α2European Journal of Immunology, 1996
- Expansion of cytokine-producing CD4-CD8- T cells associated with abnormal Fas expression and hypereosinophilia.The Journal of Experimental Medicine, 1996
- Fas and Fas ligand: lpr and gld mutationsImmunology Today, 1995
- Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia?Immunology Today, 1995
- Clonal Proliferation of Type 2 Helper T Cells in a Man with the Hypereosinophilic SyndromeNew England Journal of Medicine, 1994
- Identification of Activated T Lymphocytes and Eosinophils in Bronchial Biopsies in Stable Atopic AsthmaAmerican Review of Respiratory Disease, 1990
- Rapid, nonradioactive detection of clonal T-cell receptor gene rearrangements in lymphoid neoplasms.Proceedings of the National Academy of Sciences, 1990